Gene Query: HMG20B

Dataset Description Geneva Score
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 73.15
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 60.54
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 45.45
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 36.29
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 33.72
IDH3a KO RNA-seq 30.66
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 30.42
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 29.25
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 29.25
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 28.41
Lipid degradation promotes prostate cancer cell survival 27.12
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 24.56
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 24.03
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 23.63
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 22.76
Differential gene expression of human melanoma cells [RNA-seq] 22.42
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 22.42
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 22.28
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 22.24
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 21.83
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 21.39
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 21.39
Analysis of transcriptional regulation by Myt1 and Myt1l 21.11
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 20.6
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 20.09
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 19.39
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 19.18
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 19.04
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 19.04
An integrative analysis of non-coding regulatory DNA variations associated with autism 18.93
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.25
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 18.06
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 17.84
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 17.82
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 17.82
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 17.82
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 17.72
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 17.69
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 17.6
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 17.16
Role for citron kinase in prostate cancer growth 17.08
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 17.06
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 16.93
RNA-seq analyses of human prostate cancer cells 16.82
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 16.81
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 16.48
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 16.44
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 16.2
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 15.72
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 15.62
METTL3 promotes translation in human cancer cells 15.62
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 15.57
Transcriptome analysis of virus infected tissues 15.51
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.98
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 14.94
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 14.86
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 14.86
RNA-sequencing of formalin fixed human primary melanoma tissue 14.75
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 14.74
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 14.74
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 14.74
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 14.63
Generation and functional characterization of MDSC-like cells 14.52
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 14.26
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 14.26
Silencing SPIB in attached and floating state of H1703 lung cancer cells 14.03
RNA-seq in transgenic cells 14.01
SNHG5 siRNA knock down in HCT116 cells 13.96
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 13.9
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 13.87
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 13.78
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 13.72
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 13.68
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 13.68
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 13.66
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 13.43
The effect of PPARG inhibition on human angiomyolipoma cells 13.33
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 13.23
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 13.16
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 12.99
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 12.92
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 12.74
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 12.56
Exploring ILF2 regulatory genes by next-generation sequencing 12.49
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 12.45
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 12.39
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 12.35
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 12.35
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 12.21
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 12.17
Mitochondrial dsRNA triggers antiviral signalling in humans 11.9
U1 snRNP telescripting regulates size-function stratified human genome 11.82
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 11.73
Gene expression profiling of leukemia cells following asparagine depletion 11.66
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 11.65
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 11.53
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 11.5
AUF-1 affected genes in human skin cells 11.48
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.29
Regulation of highly expressed hCINAP on translatome 11.27
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 11.27
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 11.27
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 11.17
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 11.12
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 11.12
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 11.09
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 11.09
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 11.08
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 11.07
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.0
RNA-seq melanoma 10.99
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 10.91
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 10.85
Sensing self and nonself circular RNAs 10.84
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.73
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.73
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.7
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.64
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 10.61
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 10.57
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 10.57
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 10.56
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.53
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 10.48
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 10.48
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 10.48
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.37
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 10.33
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 10.29
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 10.25
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 10.16
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 10.0
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.0
Accurate annotation of human protein-coding small open reading frames 9.95
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 9.88
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 9.88
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.85
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 9.81
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.69
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.69
LNCaP treated with iBET 9.65
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 9.65
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 9.59
Dtx3L and Androgen Signaling in Prostate Cancer 9.45
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 9.41
RNA-seq of naive and primed ES cells (NHSM) 9.41
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.36
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 9.35
ETV7 and interferon response 9.35
Paxillin regulates genomic networks in prostate cancer [LNCaP] 9.34
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.33
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 9.3
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.25
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 9.2
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 9.07
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 9.02
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 9.02
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 9.02
Real-time observation of light-controlled transcription in living cells 8.95
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.93
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.93
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 8.89
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 8.84
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.83
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 8.82
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 8.82
Gene Expression Profiling of SPOP Knocked Down Cell 8.73
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.7
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 8.65
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 8.54
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.5
Microprocessor mediates transcription termination in long noncoding microRNA genes 8.47
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 8.42
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 8.42
Tracking of dCas9-methyltransferase footprints 8.38
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.32
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 8.29
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 8.27
scRNASeq analysis of cycling cardiomyocytes 8.24
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 8.21
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 8.2
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 8.2
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 8.2
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.2
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 8.18
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 8.14
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.09
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 8.03
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 7.99
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 7.97
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 7.93
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.87
NRDE2 negatively regulates nuclear exosome functions 7.85
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 7.84
Transcriptome profiling of Normal and Cancerous Prostate Cells 7.8
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 7.78
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 7.73
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 7.68
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 7.67
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 7.6
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 7.59
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.59
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 7.48
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 7.41
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.41
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.41
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 7.38
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 7.36
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 7.36
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 7.28
Biological effect of chronic mistranslation in mammalian cells 7.21
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.19
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.18
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.18
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.17
m6A-dependent regulation of messenger RNA stability 7.15
Paxillin regulates genomic networks in prostate cancer [C4-2] 7.13
RNA-seq of tumor cells following angiopellosis extravasation 7.09
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 7.07
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.01
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.01
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 6.91
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 6.91
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 6.91
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 6.9
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 6.9
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 6.9
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 6.88
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 6.86
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.85
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.85
Trascriptome of thyroid cancer-induced macrophages 6.83
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 6.82
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 6.82
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.81
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 6.68
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 6.68
Illumina Total RNA-seq in HeLa 6.65
Effect of from Human Umbilical Vein Endothelial Cells 6.62
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.53
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 6.52
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.49
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 6.42
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 6.42
Ebola virus (EBOV) infection of ARPE-19 cells 6.38
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 6.3
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 6.29
Expression profiling of etoposide-induced senescent cells 6.28
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.26
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 6.25
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.25
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 6.23
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 6.23
High-throughput sequencing of pluripotent cells 6.21
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 6.07
Patient-derived xenograft platform for metastatic melanoma 6.02
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.02
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 5.98
RNA-seq analysis of control and Myc-induced U2OS cells 5.85
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.82
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.82
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.82
Cellular response to hepatitis E virus (HEV) infection 5.77
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 5.72
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 5.64
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 5.55
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 5.55
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 5.47
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.46
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.45
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 5.44
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.42
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 5.35
Effect of PBK knockdown on C4-2 cell transcriptome 5.34
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 5.25
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.25
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.24
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.21
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 5.18
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 5.17
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.17
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 5.13
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 5.13
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.09
Expression profiling of MCF-7 cells with treatment of TCDD 5.08
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.08
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 4.97
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.87
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.84
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.82
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 4.82
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 4.75
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.67
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.64
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.63
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.62
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.61
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 4.58
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 4.58
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.57
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.56
Mapping interactions for the TNIP2 hub protein 4.55
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.52
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.52
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.52
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.52
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.5
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.5
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 4.5
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.44
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.44
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.44
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.43
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.41
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.38
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 4.38
Genome-wide analysis of the Integrator complex 4.37
Genome-wide analysis of the Integrator complex (HTS) 4.37
N6-methyladenine DNA Modification in Glioblastoma 4.36
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.36
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.33
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.26
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 4.17
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.16
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.15
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 4.15
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 4.15
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 4.13
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.05
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.05
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.01
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.01
RNA sequencing of human mammary epithelial cells 3.98
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.94
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.94
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.93
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.92
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.84
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.83
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.83
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.75
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.73
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.68
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.68
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.65
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.6
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.58
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.45
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 3.43
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.41
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.38
Transcriptomes of oxLDL exposed trained monocytes 3.37
oxLDL exposed trained monocytes 3.37
Genome-wide discovery of human splicing branchpoints 3.35
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.34
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.33
HEK293 TFAM Knockout Expression Study 3.32
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.3
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.23
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 3.22
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.21
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.17
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.14
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.12
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.12
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.11
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.07
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.06
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.06
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 3.01
RNA editing in nascent RNA affects pre-mRNA splicing 2.95
Investigate A2M treatment on human prostate cancer and mouse liver 2.94
Investigate A2M treatment on human prostate cancer xenograft in mice 2.94
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.93
NAPRT activation of macrophages 2.9
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.88
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.87
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.84
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.81
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.78
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.72
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 2.7
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 2.68
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.62
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.62
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.55
KLF6-dependent transcription in renal cancer cells 2.55
Androgen Receptor-regulated genes in prostate cancer cells 2.51
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.51
Profiling of escape kinetics of viruses subjected to RNAi 2.5
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.49
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.46
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.46
Ribosome profiling upon inhibition of eIF4A 2.46
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.45
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.42
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.41
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.41
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.35
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.34
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.28
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.21
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.04
BASP1 modifies the Tamoxifen response 1.91
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 1.83
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.83
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.83
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.75
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.75
The bromodomain protein BRD4 regulates splicing during heat shock 1.75
Interaction between mitoNEET and NAF-1 in cancer cells 1.72
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.72
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.72
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.64
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.62
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 1.55
Enhancer activation during EGF response 1.53
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.47
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.47
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.43
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.41
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.41
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.37
Finding missing proteins from epigenetically manipulated human cells 1.32
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.32
The role of m6A/m-RNA methylation in stress response regulation 1.31
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.31
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.29
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.29
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.27
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.26
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.24
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.2
Capturing the Interactome of Newly Transcribed RNA 1.2
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.14
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.14
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.13
Transcriptomic analysis of human macrophages in 3D 1.13
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.07
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 1.06
Induced DNA demethylation, genome instability and transcription 1.04
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.04
RNA seq_PDX2_SHP099 1.04
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.99
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.98
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.94
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.89
Co-regulation of splicing by Rbfox1 and hnRNP M 0.89
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.88
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.86
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.86
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.85
Ribosomal protein RPL26 is the principal target of UFMylation 0.8
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.79
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.79
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.78
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.78
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.78
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.73
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.69
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.67
MHC Transcriptomic landscape at haplotype-specific resolution 0.66
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.63
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.61
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.57
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.56
The role of the Calcium-Sensing receptor in colorectal cancer 0.53
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.52
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.52
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.52
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.47
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.47
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.47
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.47
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.44
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.44
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.43
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.41
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.41
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.38
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.38
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.34
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.34
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.33
Tpl-2 and MEK small molecule inhibitors 0.31
Tpl-2 small molecule project 0.31
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.31
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.29
Comparative Analysis of Cas9 Activators Across Multiple Species 0.27
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.26
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.26
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.26
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.2
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.07
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.06
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.05
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.04
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation